We are building the bridge between complex molecular data and everyday clinical decisions
Community healthcare initiatives reach a milestone year, with services spanning 90 districts, 22 states, and over 70 lakh cumulative beneficiaries since 2006
Seasoned pharmaceutical marketing leader brings extensive experience in brand management, sales strategy, and digital engagement to the expanded leadership role
Veteran healthcare leader with extensive experience in hospital operations will drive operational excellence, patient-centric care, and sustainable growth in his new role
Ranluspec is the only interchangeable ranibizumab biosimilar approved in the United States in both vial and pre-filled syringe (PFS) presentations
Built on Snowflake Cortex AI, the agent enables representatives to generate comprehensive pre-call plans through a single conversational interface
Teva said the launch strengthens its biosimilars strategy and expands access to biologic medicines across Europe
Anbalagan has led end-to-end product development programs from concept to commercialization, with a strong focus on regulatory compliance, process scalability, and manufacturing readiness
Company expands injectable portfolio with therapeutically equivalent version of Vimpat®, targeting a market valued at approximately $15.2 million annually
MSD joins as anchor customer as Aurobindo strengthens its position in the fast-growing global biologics manufacturing market
Subscribe To Our Newsletter & Stay Updated
